Market capitalization | $15.45m |
Enterprise Value | $16.85m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.89 |
P/S ratio (TTM) P/S ratio | 1.73 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | -1.21% |
Revenue (TTM) Revenue | $8.92m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
3 Analysts have issued a Aspira Women`s Health Inc forecast:
3 Analysts have issued a Aspira Women`s Health Inc forecast:
Jun '24 |
+/-
%
|
||
Revenue | 8.92 8.92 |
1%
1%
|
|
Gross Profit | 5.16 5.16 |
0%
0%
|
|
EBITDA | -17 -17 |
27%
27%
|
EBIT (Operating Income) EBIT | -17 -17 |
27%
27%
|
Net Profit | -16 -16 |
23%
23%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. The company serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.
Head office | United States |
CEO | Nicole Sandford |
Employees | 64 |
Founded | 1993 |
Website | www.aspirawh.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.